Early Communication About Safety of Lantus (insulin glargine)
This is a discussion on Early Communication About Safety of Lantus (insulin glargine) within the FDA News forum, part of the Industry News and Updates category; FDA is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-01-2009, 11:14 AM
|
|||
|
|||
Early Communication About Safety of Lantus (insulin glargine)
FDA is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible risk for cancer in patients with diabetes.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA issues an Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix) | industry_news | FDA News | 0 | 01-26-2009 01:09 PM |
| FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates | industry_news | FDA News | 0 | 11-12-2008 11:48 AM |
| Epoetin alfa - Early Communication about an Ongoing Safety Review | industry_news | FDA News | 0 | 09-26-2008 12:42 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. | industry_news | FDA News | 0 | 08-22-2008 03:44 PM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |